Drugs + Money
Eurasian States Pouring Money Into Incarceration, Not Harm Reduction
Harm reduction funding around the world is stalling. By extension, harm reductionists in Eastern ...
Global Drug Survey: Large Majority of Cocaine Users Would Pay More for Safer, “Fair Trade” Supply
As the international cocaine supply becomes increasingly risky, most people who use the drug ...
Gilead Relinquishes Its PrEP Patent—But Did It Mislead Investors?
On May 8, pharmaceutical company Gilead quietly announced that it will relinquish its exclusive ...
Maine Hit Hard by Overdose Crisis, Yet Suffers Biggest Federal Funding Shortfall
Funding for harm reduction interventions in Maine received a much-needed boost on February 6. ...
Bernie Sanders Backs #BreakThePatent Fight for Universal PrEP Access
The fight for universal access to PrEP medication for HIV prevention was picked up ...
New “Generic” Naloxone: Expect More Big-Pharma Sleight of Hand
It’s been less than two weeks since the US Department of Justice joined a ...
Cannabis Consumers Have Power: Meet Some Pioneers of Industry Inclusivity
In the hyper-commodifying cannabis industry, Mary Pryor of New York City is raising her ...
Hep C Treatment Is Scarce Behind Bars—And Jeopardized Upon Release
In April 2010, Sean tested positive for the hepatitis C virus (HCV) in Seattle’s ...
Indivior Case: Don’t Throw Out the Buprenorphine With the Bathwater
In the lucrative but hit-and-miss opioid use disorder treatment field, buprenorphine is one medication ...
The Justice Gap: Trump Budget Attack on Legal Aid Orgs Targets Drug Users, HIV-Positive People
Many of the policies peddled by the Trump administration sound like a broken record. ...
